Loading...
*  Monocytic leukemia
... is a type of myeloid leukemia characterized by a dominance of monocytes in the marrow. When the monocytic ... Monocytic leukemia is almost always broken down into "acute" and "chronic": acute monocytic leukemia chronic myelomonocytic ... cells are predominantly monoblasts, it can be subclassified into acute monoblastic leukemia. ...
*  Childhood leukemia
JMML begins from myeloid cells, but is not as fast-growing as AML or as slow as CML. The exact cause of most cases of childhood ... Childhood leukemia is a type of leukemia, usually acute lymphocytic leukemia (ALL), and a type of childhood cancer. The cure ... One main type of acute leukemia is acute lymphocytic leukemia (ALL), which accounts for about 3 out of 4 cases of leukemia in ... These chronic leukemias are divided into two types: chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). ...
*  Myeloid leukemia
... is a type of leukemia affecting myeloid tissue. Types include: Acute myeloid leukemia Chronic myelogenous ...
*  Acute myeloid leukemia
... at Curlie (based on DMOZ) GeneReviews/NIH/NCBI/UW entry on Familial Acute Myeloid Leukemia (AML) with ... Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal ... Cure rates for promyelocytic leukemia can be as high as 98%. Acute myeloid leukemia is a relatively rare cancer. There are ... "Adult Acute Myeloid Leukemia Treatment". National Cancer Institute. 6 March 2017. Retrieved 19 December 2017. "Acute Myeloid ...
*  Atypical chronic myeloid leukemia
... (aCML) is a type of leukemia. It is a heterogeneous disorder belonging to the group of ... Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study. Am J Epidemiol 172, 1028- ... Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344, 1031- ... The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and ...
*  Acute myeloid dendritic cell leukemia
... is an exceedingly rare form of leukemia. This form of leukemia represents only about 0.8 ... of myeloid dendritic cell is less common and it leads to a form of leukemia known as acute myeloid dendritic cell leukemia. The ... In the case of acute myeloid dendritic cell leukemia, the blast cells are positive for markers of dendritic cells or monocytes ... of all cases of acute myeloid leukemia. Dendritic cells function as antigen-presenting cells. They process antigen material and ...
*  Acute erythroid leukemia
... or Di Guglielmo syndrome is a rare form of acute myeloid leukemia (less than 5% of AML cases) where ... Acute erythroid leukemia is rare, accounting for only 3-5% of all acute myeloid leukemia cases. One study estimated an ... These cases are now likely to instead be classified as acute myeloid leukemia with myelodysplasia-related changes or therapy- ... Naiem F, Rao PN (2009). "Acute Myeloid Leukemia". Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular ...
*  List of hematologic conditions
Löwenberg B, Downing JR, Burnett A (Sep 30, 1999). "Acute myeloid leukemia". N Engl J Med (Review). 341 (14): 1051-62. doi: ... Leukemia is a malignancy producing of white blood cells in bone marrow. It can be a serious disease if not treated early. ... These cancers include leukemias, lymphomas, and myelomas. These particular types of cancers can arise as defected mature cell ... "Leukemia - Chronic Lymphocytic - CLL". Cancer.Net. American Society of Clinical Oncology (ASCO). December 2, 2010. Retrieved 2 ...
*  PCNT
... chronic myeloid leukemia (CML); bipolar affective disorder; and other congenital disorders . In particular, the short stature ...
*  Sarcoidosis
There have been reports of hairy cell leukemia, acute myeloid leukemia, and acute myeloblastic leukemia associated with ... CS1 maint: Multiple names: authors list (link) Maloisel F, Oberling F; Oberling (1992). "Acute myeloid leukemia complicating ... CS1 maint: Multiple names: authors list (link) Schiller G, Said J, Pal S; Said; Pal (2003). "Hairy cell leukemia and ... Reich JM (1985). "Acute myeloblastic leukemia and sarcoidosis. Implications for pathogenesis". Cancer. 55 (2): 366-9. doi: ...
*  Vinca
"Chemotherapy for Chronic Myeloid Leukemia". cancer.org. American Cancer Society. February 22, 2016. Retrieved June 22, 2017. " ... "Chemotherapy for Childhood Leukemia". cancer.org. American Cancer Society. February 3, 2016. Retrieved June 22, 2017. " ... "Chemotherapy for Acute Lymphocytic Leukemia". cancer.org. American Cancer Society. February 18, 2016. Retrieved June 22, 2017 ... and is used to treat some leukemias, lymphomas, and childhood cancers, as well as several other types of cancer and some non- ...
*  Acute panmyelosis with myelofibrosis
Controversy remains today whether this disorder is a subtype of acute myeloid leukemia or myelodysplastic syndromes; however, ... May 2005). "Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia". Mod. Pathol. 18 (5 ...
*  HAP1 cells
KBM-7 was found in a patient with chronic myeloid leukemia (CML). This cell line has a haploid karyotype except for chromosomes ... Philadelphia chromosomes are common in myeloid leukemia cells. After its discovery, subsequent experiments have resulted in the ... HAP1 cells are derived from leukemic cells, which develop from mutated myeloid cells in the bone marrow. Healthy myeloid cells ... "What is chronic myeloid leukemia?". www.cancer.org. Retrieved 2016-04-14. Cellosaurus entry for HAP1. ...
*  DNA (cytosine-5)-methyltransferase 3A
December 2010). "DNMT3A mutations in acute myeloid leukemia". The New England Journal of Medicine. 363 (25): 2424-33. doi: ... Shih AH, Abdel-Wahab O, Patel JP, Levine RL (September 2012). "The role of mutations in epigenetic regulators in myeloid ... mutated genes identified in the Cancer Genome Atlas project DNMT3A mutations were most commonly seen in acute myeloid leukaemia ...
*  Lestaurtinib
22 January 2016). "New drugs in acute myeloid leukemia". Annals of Oncology. 27 (5): 770-8. doi:10.1093/annonc/mdw015. ... "Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia". ... as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy". Blood. ... Since leukemias typically develop multiple pathways of survival, lestaurtinib was studied in conjunction with traditional ...
*  Charles Sawyers
"Molecularly targeted treatments for chronic myeloid leukemia , The Lasker Foundation". The Lasker Foundation. Retrieved 5 April ... for the development of the ABL kinase inhibitor imatinib for patients with chronic myeloid leukemia and the second generation ... Grindlinger, Brooke; Chao, ES (1 October 2009). "Trio receives Lasker Foundation Clinical Award for breakthroughs in leukemia ...
*  MLF1
Myeloid leukemia factor 1 is a protein that in humans is encoded by the MLF1 gene. GRCh38: Ensembl release 89: ENSG00000178053 ... "Entrez Gene: MLF1 myeloid leukemia factor 1". Lim R, Winteringham LN, Williams JH, et al. (2002). "MADM, a novel adaptor ... 2005). "Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3". EMBO J. 24 (9): 1739-49. ... 2003). "Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia". Hum. Pathol. 34 (8): 809-13 ...
*  Ponatinib
... or blast phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia for whom no other ... "Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia". Zhou T, Commodore L, Huang WS, Wang Y, Thomas M, Keats J, Xu Q, Rivera ... "The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the ... "ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia ...
*  NPM1
Chen W, Rassidakis GZ, Medeiros LJ (2006). "Nucleophosmin gene mutations in acute myeloid leukemia". Arch. Pathol. Lab. Med. ... Meani, Natalia; Alcalay, Myriam (2014). "Role of nucleophosmin in acute myeloid leukemia". Expert Review of Anticancer Therapy ... Of high importance is NPM involvement in acute myelogenous leukemia, where a mutated protein lacking a folded C-terminal domain ... Strategies against this subtype of acute myelogenous leukemia include the refolding of the C-terminal domain using ...
*  CLIP (protein)
CLIP plays a role in myeloid leukemia. in the MHC's peptide binding site Abbas K, Lichtman S, Pillai: Cellular and Molecular ... in MHC antigen processing modulates immune responses in myeloid leukemia. ...
*  Proto-oncogene tyrosine-protein kinase Src
One notable example is dasatinib which has been approved for the treatment of chronic myeloid leukemia (CML) and Philadelphia ... Breccia M, Salaroli A, Molica M, Alimena G (2013). "Systematic review of dasatinib in chronic myeloid leukemia". Onco Targets ... Amsberg GK, Koschmieder S (2013). "Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia ... chromosome-positive (PH+) acute lymphocytic leukemia (ALL). Dasatinib is also in clinical trials for the use in non-Hodgkin's ...
*  Chromosome 5 (human)
One example would be acute myeloid leukemia (AML). The following are some of the gene count estimates of human chromosome 5. ...
*  RHOA
Chronic Myeloid Leukemia (CML), a stem cell disorder that prevents myeloid cells from functioning correctly, has been linked to ... Molli PR, Pradhan MB, Advani SH, Naik NR (2012). "RhoA: A therapeutic target for chronic myeloid leukemia". Molecular cancer. ... "Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF". Proc. Natl. Acad. Sci. U.S.A. 100 ( ...
*  Cyclophosphamide
Secondary acute myeloid leukemia (therapy-related AML, or "t-AML") is thought to occur either by cyclophosphamide-inducing ... Larson RA (2007). "Etiology and management of therapy-related myeloid leukemia". Hematology. 2007: 453-9. doi:10.1182/ ... Cyclophosphamide-induced leukemia will often involve complex cytogenetics, which carries a worse prognosis than de novo AML.[ ... As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer ...
*  SETBP1
... specific somatic mutations of this gene were discovered in patients affected by atypical Chronic Myeloid Leukemia (aCML) and ... "Recurrent SETBP1 mutations in atypical chronic myeloid leukemia". Nature Genetics. 45 (1): 18-24. doi:10.1038/ng.2495. PMC ... "Recurrent SETBP1 mutations in atypical chronic myeloid leukemia". Nature Genetics. 45 (1): 18-24. doi:10.1038/ng.2495. PMC ... a novel protein that binds to the acute undifferentiated leukemia-associated protein SET". European Journal of Biochemistry / ...
*  Interferon
... leukemia and lymphomas including hairy cell leukemia, chronic myeloid leukemia, nodular lymphoma, and cutaneous T-cell lymphoma ...
*  Targeted alpha-particle therapy
Jurcic, Joseph G.; Rosenblat, Todd L. (2014). "Targeted Alpha-Particle Immunotherapy for Acute Myeloid Leukemia". American ... Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, ...